Relationships Between Nutritional Status and Serum Adipokine Levels with Chemotherapy Efficacy in Late-stage Colorectal Cancer Patients

Overview

Journal Int J Colorectal Dis

Date 2025 Jan 28

PMID 39873770

Authors

Wendi Zhang

Shanshan Wang

Affiliations

Soon will be listed here.

Abstract

Objective: Colorectal cancer (CRC) is a common cancer, with chemotherapy as its major therapy. Nutritional status (NS) and adipokines implicated in CRC. We explored the impacts of NS indicators (hemoglobin, albumin, and prealbumin) and serum adipokine (visfatin, adiponectin, and resistin) level on chemotherapy efficacy in late-stage CRC patients.

Methods: Late-stage CRC patients were divided into the effective and ineffective groups based on chemotherapy efficacy, with clinical data, NS indicator, and serum adipokine levels documented. They were divided into hemoglobin, albumin, prealbumin, visfatin, adiponectin, and resistin high and low expression groups, with their relationships with clinical parameters and chemotherapy efficacy analyzed. Independent risk factors (IRFs) affecting chemotherapy efficacy in late-stage CRC patients were analyzed by logistic multivariate regression.

Results: Hemoglobin, albumin, prealbumin, and adiponectin levels were reduced, while NRS 2002 ≥ 3 proportion, visfatin, and resistin levels were increased in the ineffective group versus the effective group. Areas under receiver operating characteristic curve of hemoglobin, albumin, prealbumin, visfatin, adiponectin, and resistin in diagnosing ineffective chemotherapy were 0.80, 0.88, 0.86, 0.88, 0.83, and 0.83, respectively. NS indicator and serum adipokine levels were markedly associated with chemotherapy efficacy in late-stage CRC patients. Highly expressed albumin and prealbumin were protective factors for effective chemotherapy, and highly expressed visfatin and resistin were risk factors for effective chemotherapy.

Conclusion: NS indicators and serum adipokine level are correlated with the chemotherapy efficacy in late-stage CRC patients, and both have diagnostic value for chemotherapy efficacy. Albumin, prealbumin, visfatin, and resistin are independent influencing factors affecting chemotherapy efficacy in late-stage CRC patients.

References

Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y . Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 2003; 9(15):5699-704. View

Mihajlovic M, Ninic A, Sopic M, Miljkovic M, Stefanovic A, Vekic J . Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine. EPMA J. 2019; 10(3):307-316. PMC: 6695467. DOI: 10.1007/s13167-019-00178-x. View

Lv L, Sun X, Liu B, Song J, Wu D, Gao Y . Genetically Predicted Serum Albumin and Risk of Colorectal Cancer: A Bidirectional Mendelian Randomization Study. Clin Epidemiol. 2022; 14:771-778. PMC: 9233496. DOI: 10.2147/CLEP.S367547. View

Slomian G, Swietochowska E, Malinowska-Borowska J, Kasperczyk S, Rogalska A, Nowak P . Association between chemotherapy and plasma adipokines in patients with colorectal cancer. Pharmacol Rep. 2014; 66(5):902-7. DOI: 10.1016/j.pharep.2014.05.015. View

Wimmer E, Glaus A . Early identification of cancer-related malnutrition in patients with colorectal cancer before and after surgery: a literature review. Support Care Cancer. 2022; 30(11):8775-8783. PMC: 9633510. DOI: 10.1007/s00520-022-07230-z. View

Truong A, Hanna M, Moghadamyeghaneh Z, Stamos M . Implications of preoperative hypoalbuminemia in colorectal surgery. World J Gastrointest Surg. 2016; 8(5):353-62. PMC: 4872063. DOI: 10.4240/wjgs.v8.i5.353. View

Yang G, Fan W, Luo B, Xu Z, Wang P, Tang S . Circulating Resistin Levels and Risk of Colorectal Cancer: A Meta-Analysis. Biomed Res Int. 2016; 2016:7367485. PMC: 5013211. DOI: 10.1155/2016/7367485. View

Alvaro Sanz E, Garrido Siles M, Rey Fernandez L, Roldan R, Dominguez A, Abiles J . Nutritional risk and malnutrition rates at diagnosis of cancer in patients treated in outpatient settings: Early intervention protocol. Nutrition. 2018; 57:148-153. DOI: 10.1016/j.nut.2018.05.021. View

Salageanu A, tucureanu C, Lerescu L, Caras I, Pitica R, Gangura G . Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life. 2011; 3(4):416-20. PMC: 3019064. View

10.

Gupta A, Gupta E, Hilsden R, Hawel J, Elnahas A, Schlachta C . Preoperative malnutrition in patients with colorectal cancer. Can J Surg. 2021; 64(6):E621-E629. PMC: 8628841. DOI: 10.1503/cjs.016820. View

11.

Sugaya M, Maio R, Soares B, Calado C, Morais G, de Arruda I . Discriminative power of an adapted version of Nutritional Risk Screening 2002 applied to Brazilian older adults. Einstein (Sao Paulo). 2020; 18:eAO5309. PMC: 8639137. DOI: 10.31744/einstein_journal/2020AO5309. View

12.

Lewandowska A, Religioni U, Czerw A, Deptala A, Karakiewicz B, Partyka O . Nutritional Treatment of Patients with Colorectal Cancer. Int J Environ Res Public Health. 2022; 19(11). PMC: 9180662. DOI: 10.3390/ijerph19116881. View

13.

Wang C, Wang Y, Huang B, Tang C, Du Z, Zeng Y . High Expression of Both Resistin and Fascin-1 Predicts a Poor Prognosis in Patients with Colorectal Cancer. Biomed Res Int. 2020; 2020:8753175. PMC: 7201636. DOI: 10.1155/2020/8753175. View

14.

Biller L, Schrag D . Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021; 325(7):669-685. DOI: 10.1001/jama.2021.0106. View

15.

Knight K, Wade S, Balducci L . Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med. 2004; 116 Suppl 7A:11S-26S. DOI: 10.1016/j.amjmed.2003.12.008. View

16.

Lichtenstern C, Ngu R, Shalapour S, Karin M . Immunotherapy, Inflammation and Colorectal Cancer. Cells. 2020; 9(3). PMC: 7140520. DOI: 10.3390/cells9030618. View

17.

Jiang Z, Li Y, Han G, Zhang J, Li Z, Wang D . [Association of serum albumin level with clinicopathologic features and prognosis in colon cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2016; 19(1):80-3. View

18.

Wei Y, Hong C, Zhao C, Liang G, Wang G, Zou X . [Clinicopathological features and prognosis of colorectal cancer patients with preoperative cancer-related anemia]. Zhonghua Wei Chang Wai Ke Za Zhi. 2012; 15(4):385-7. View

19.

Liu H, Song B, Jin J, Liu Y, Wen X, Cheng S . Nutritional Risk, Health Outcomes, and Hospital Costs Among Chinese Immobile Older Inpatients: A National Study. Front Nutr. 2021; 8:758657. PMC: 8703034. DOI: 10.3389/fnut.2021.758657. View

20.

Cai W, Kong W, Dong B, Zhang J, Chen Y, Xue W . Pretreatment Serum Prealbumin as an Independent Prognostic Indicator in Patients With Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors as First-Line Target Therapy. Clin Genitourin Cancer. 2017; 15(3):e437-e446. DOI: 10.1016/j.clgc.2017.01.008. View